Mallinckrodt Pharmaceuticals
MNK
$0.61
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - Net assets
Net assets on the balance sheet as of June 2023 : NZ$1.11 Billion
According to Mallinckrodt Pharmaceuticals
's latest financial reports the company has NZ$1.11 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Mallinckrodt Pharmaceuticals - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $NZ$2.54 B | 453.94% |
| 2021-12-31 | $NZ$0.45 B | -67.52% |
| 2020-12-31 | $NZ$1.41 B | -50.98% |
| 2019-12-31 | $NZ$2.88 B | -33.06% |
| 2018-12-31 | $NZ$4.30 B | -53.13% |
| 2017-12-31 | $NZ$9.18 B | |
| 2016-09-30 | $NZ$7.27 B | -12.98% |
| 2015-09-30 | $NZ$8.35 B | 30.9% |
| 2014-09-30 | $NZ$6.38 B | 320.47% |
| 2013-09-30 | $NZ$1.51 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | NZ$127.85 B | 11,331.08% | 🇺🇸 USA |
 | NZ$10.23 B | 814.61% | 🇮🇱 Israel |
 | NZ$34.99 B | 3,028.40% | 🇺🇸 USA |